|
|
|
A physician on the Elmhurst Memorial Hospital medical staff is the first in Chicago area to implant two new heart devices, the hospital said.
The physician implanted the the Unify Quadra cardiac resynchronization therapy defibrillator (CRTD) and Quartet Left Ventricular Quadripolar Pacing Lead.
The new pacing technology offers additional pacing options that can reduce the need for reoperation to reposition a lead and offers physicians the ability to more efficiently and effectively manage the individualized needs of patients with heart failure.
“This technology is the industry’s first quadripolar pacing system, and we are proud to be among the first in the country to implant this state of the art device,” said Dr. Cash Casey, a cardiologist with Midwest Heart Specialists and member of the EMH medical staff. “We’re committed to providing our patients with smart technology that will help improve their quality of life. We recognize the advancements found in the latest CRT device and are excited to have this as an option for our patients.”
Offering this new pacing technology represents the latest example of EMH’s commitment to remaining on the cutting edge of the latest treatment options. In 2011, immediately following approval by the U.S. Food and Drug Administration, a revolutionary new treatment for atrial fibrillation was performed for the first time in Illinois at EMH.
The procedure, which uses the Artic Front Cardiac CryoAblation Catheter System, is a minimally invasive, catheter-based technology that blocks the conduction of atrial fibrillation in cardiac tissue through the use of a balloon that cools tissue rather than the traditional approach of heating tissue with a catheter, the hospital said.
The Quartet lead now being used by Dr. Casey at EMH features four electrodes on a single, left-ventricular lead — or wire — instead of the current industry standard of two electrodes on a bipolar lead.
The additional electrodes provide more ways for a physician to configure an optimal pacing strategy while still implanting the lead in the most stable position. Ultimately, having four electrodes provides more options to effectively regulate the patient’s heartbeat.
For more information about Elmhurst Memorial Healthcare (331) 2212273, or visit our website at www.emhc.org.
A physician on the Elmhurst Memorial Hospital medical staff is the first in Chicago area to implant two new heart devices, the hospital said.
The physician implanted the the Unify Quadra cardiac resynchronization therapy defibrillator (CRTD) and Quartet Left Ventricular Quadripolar Pacing Lead.
The new pacing technology offers additional pacing options that can reduce the need for reoperation to reposition a lead and offers physicians the ability to more efficiently and effectively manage the individualized needs of patients with heart failure.
“This technology is the industry’s first quadripolar pacing system, and we are proud to be among the first in the country to implant this state of the art device,” said Dr. Cash Casey, a cardiologist with Midwest Heart Specialists and member of the EMH medical staff. “We’re committed to providing our patients with smart technology that will help improve their quality of life. We recognize the advancements found in the latest CRT device and are excited to have this as an option for our patients.”
Offering this new pacing technology represents the latest example of EMH’s commitment to remaining on the cutting edge of the latest treatment options. In 2011, immediately following approval by the U.S. Food and Drug Administration, a revolutionary new treatment for atrial fibrillation was performed for the first time in Illinois at EMH.
The procedure, which uses the Artic Front Cardiac CryoAblation Catheter System, is a minimally invasive, catheter-based technology that blocks the conduction of atrial fibrillation in cardiac tissue through the use of a balloon that cools tissue rather than the traditional approach of heating tissue with a catheter, the hospital said.
The Quartet lead now being used by Dr. Casey at EMH features four electrodes on a single, left-ventricular lead — or wire — instead of the current industry standard of two electrodes on a bipolar lead.
The additional electrodes provide more ways for a physician to configure an optimal pacing strategy while still implanting the lead in the most stable position. Ultimately, having four electrodes provides more options to effectively regulate the patient’s heartbeat.
For more information about Elmhurst Memorial Healthcare (331) 2212273, or visit our website at www.emhc.org.
